ArticleBMJ open2025

Impact of real-time glucose monitoring using FreeStyle Libre 3 on glycaemia in type 2 diabetes managed with basal insulin plus SGLT2 inhibitor and/or GLP-1 agonist: the FreeDM2 randomised controlled trial protocol.

Emma G Wilmot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.